Eli Lilly and Company ( LLY) - Stock Earnings
LLY Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 6.6 billion USD | 19.3 billion USD |
| 2026Q1 | 7.4 billion USD | 19.8 billion USD |
| 2026Q2 | 7.1 billion USD | 23.0 billion USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
LLY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 5.2 billion USD | 34.1 billion USD |
| 2024 | 10.6 billion USD | 45.0 billion USD |
| 2025 | 20.6 billion USD | 65.2 billion USD |
| 2026 Est. | — | — |
LLY
Price: $1,148.20
Dividend Yield: 0.58%
Forward Dividend Yield: 0.60%
Payout Ratio: 63.73%
Dividend Per Share: 6.92 USD
Earnings Per Share: 29.81 USD
P/E Ratio: 40.76
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 2.6 million
Ebitda: 758.9 millionMarket Capitalization: 1.1 trillion
Average Dividend Frequency: 4
Years Paying Dividends: 55
DGR3: 16.81%
DGR5: 16.09%
DGR10: 11.89%
DGR20: 7.42%